$2.65
0.01 (+0.38%)
GenVec, Inc. (NASDAQ:GNVC)
CAPS Rating:
A biopharmaceutical company, which develops novel gene-based therapeutic drugs and vaccines.
The Official Website of the Long-Term Investor
A biopharmaceutical company, which develops novel gene-based therapeutic drugs and vaccines.
BATS data provided in real-time. NYSE, NASDAQ and AMEX data delayed 15 minutes.
Real-Time prices provided by BATS. Market data provided by Interactive Data.
Company fundamental data provided by Morningstar. Earnings Estimates and Analyst Ratings provided by Zacks.
SEC Filings and Insider Transactions provided by Edgar Online.
Powered and implemented by Interactive Data Managed Solutions. Terms & Conditions
RSS Headlines
Fool UK